Comparison of Outcomes With Multifocal Intraocular Lenses

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to compare and evaluate the clinical outcomes of 6 kinds of Multifocal Intraocular Lenses: SN6AD1, SBL-3, LS-313 MF30, AT LISA tri 839 MP, ART, LS-313 MF30T.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 80
Healthy Volunteers: f
View:

• Age from 40 to 80 years old, either gender;

• Patients with bilateral age related cataracts, require bilateral cataract phacoemulsification combined Intraocular Lens implantation;

• Willing to undergo second eye surgery within 7 days after first eye surgery;

• The potential postoperative visual acuity of 20/40 or better in both eyes;

• Preoperative measurement of corneal astigmatism indicate the subjects are suitable for multifocal intraocular lenses implantation;

• Capability to understand the informed consent and willing and able to attend study

Locations
Other Locations
China
The Eye Hispital of Wenzhou Medical University
RECRUITING
Wenzhou
Contact Information
Primary
AYong Yu, MD. PhD.
yaybetter@hotmail.com
+86-0577-88068880
Time Frame
Start Date: 2016-02
Estimated Completion Date: 2026-06
Participants
Target number of participants: 90
Treatments
Active_comparator: SN6AD1 group
Bilateral cataract surgery with implantation of SN6AD1 multifocal IOLs
Active_comparator: SBL-3 group
Bilateral cataract surgery with implantation of SBL-3 multifocal IOLs
Active_comparator: LS-313 MF30 group
Bilateral cataract surgery with implantation of LS-313 MF30 multifocal IOLs
Active_comparator: AT LISA tri 839 MP group
Bilateral cataract surgery with implantation of AT LISA tri 839 MP multifocal IOLs
Active_comparator: ART group
Bilateral cataract surgery with implantation of ART toric multifocal IOLs
Active_comparator: LS-313 MF30T group
Bilateral cataract surgery with implantation of LS-313 MF30T toric multifocal IOLs
Related Therapeutic Areas
Sponsors
Leads: Wenzhou Medical University

This content was sourced from clinicaltrials.gov